{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:15:18Z","timestamp":1781882118535,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03582-0","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:51:49Z","timestamp":1759150309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mendelian randomization analysis reveals no causal association between non-alcoholic fatty liver disease and hepatocellular carcinoma: implications for lipid metabolomics and shared pathophysiological mechanisms"],"prefix":"10.1007","volume":"16","author":[{"given":"Yingying","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"3582_CR1","doi-asserted-by":"crossref","unstructured":"Dong H, Yang X, Zhou Y, Yang M, Zhang H, Liu X, Zhu W. Kudzu resistant starch effectively ameliorates non-alcoholic fatty liver disease by protecting the gut microbiota intestinal barrier and suppressing inflammatory responses. J Sci Food Agric 2025.","DOI":"10.1002\/jsfa.14371"},{"key":"3582_CR2","doi-asserted-by":"publisher","first-page":"1610498","DOI":"10.3389\/fphar.2025.1610498","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang T, Han J, Song J, Yang C, Liang L, Li H, Wang H. Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease. Front Pharmacol. 2025;16:1610498.","journal-title":"Front Pharmacol"},{"key":"3582_CR3","doi-asserted-by":"publisher","first-page":"120158","DOI":"10.1016\/j.jep.2025.120158","volume":"352","author":"RY Zhou","year":"2025","unstructured":"Zhou RY, Song Q, Hu H, Zeng SY, Tan XY, Geng ZJ, Feng ZG. Investigating therapeutic effects and the underlying mechanisms of jia-wei-yin-chen-hao-tang in non-alcoholic fatty liver disease based on network Pharmacology analysis and experimental validation. J Ethnopharmacol. 2025;352:120158.","journal-title":"J Ethnopharmacol"},{"key":"3582_CR4","doi-asserted-by":"publisher","first-page":"107425","DOI":"10.1016\/j.bioorg.2024.107425","volume":"147","author":"S Iqbal","year":"2024","unstructured":"Iqbal S, Sebhaoui J, Ashraf S, Ozcan M, Kim W, Belmen B, Yesilyurt G, Hanashalshahaby E, Zhang C, Uhlen M, et al. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma. Bioorg Chem. 2024;147:107425.","journal-title":"Bioorg Chem"},{"issue":"3","key":"3582_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s13304-024-01833-3","volume":"76","author":"YH Yen","year":"2024","unstructured":"Yen YH, Kuo FY, Eng HL, Liu YW, Yong CC, Wang CC, Li WF, Lin CY. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes. Updates Surg. 2024;76(3):879\u201387.","journal-title":"Updates Surg"},{"key":"3582_CR6","doi-asserted-by":"publisher","first-page":"e17002","DOI":"10.7717\/peerj.17002","volume":"12","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Gao Y, Deng L, Lu X, Lai Y, Wu J, Chen S, Li C, Liang H. Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinoma. PeerJ. 2024;12:e17002.","journal-title":"PeerJ"},{"key":"3582_CR7","doi-asserted-by":"crossref","unstructured":"Zhang W, Li MY, Li ZQ, Diao YK, Liu XK, Guo HW, Wu XC, Wang H, Wang SY, Zhou YH et al. Long-term outcomes following hepatectomy in patients with lean non-alcoholic fatty liver disease-associated hepatocellular carcinoma versus overweight and obese counterparts: A multicenter analysis. Asian J Surg 2024.","DOI":"10.1016\/j.asjsur.2024.07.089"},{"key":"3582_CR8","doi-asserted-by":"publisher","first-page":"1306091","DOI":"10.3389\/fendo.2024.1306091","volume":"15","author":"JQ Zhu","year":"2024","unstructured":"Zhu JQ, Liu JZ, Yang SW, Ren ZY, Ye XY, Liu Z, Li XL, Han DD, He Q. Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma. Front Endocrinol (Lausanne). 2024;15:1306091.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3582_CR9","doi-asserted-by":"crossref","unstructured":"Ouyang J, Li N, Liu C, Zhang Y. Nanobubble-mediated sonodynamic therapy enhances Cuproptosis in the treatment of hepatocellular carcinoma. Nanoscale Adv 2025.","DOI":"10.1039\/D5NA00280J"},{"issue":"3","key":"3582_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.14740\/wjon2571","volume":"16","author":"K Shichiri","year":"2025","unstructured":"Shichiri K, Tung KH, Takabe K, Bartlett DL. Immune checkpoint Inhibition for hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-Cholangiocarcinoma. World J Oncol. 2025;16(3):243\u201353.","journal-title":"World J Oncol"},{"key":"3582_CR11","doi-asserted-by":"publisher","first-page":"1451965","DOI":"10.3389\/fimmu.2025.1451965","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang C, Yin J, Li N. Conversion therapy with TACE, tkis, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma. Front Immunol. 2025;16:1451965.","journal-title":"Front Immunol"},{"key":"3582_CR12","doi-asserted-by":"crossref","unstructured":"Crick DCP, Halligan SL, Davey Smith G, Khandaker GM, Jones HJ. The relationship between polyunsaturated fatty acids and inflammation: evidence from cohort and Mendelian randomization analyses. Int J Epidemiol 2025, 54(4).","DOI":"10.1093\/ije\/dyaf065"},{"issue":"25","key":"3582_CR13","doi-asserted-by":"publisher","first-page":"e42880","DOI":"10.1097\/MD.0000000000042880","volume":"104","author":"C Fan","year":"2025","unstructured":"Fan C, Huang S, Xiang C, Song Y. Evaluating the effect of Metformin on sarcopenia: A Mendelian randomization study. Med (Baltim). 2025;104(25):e42880.","journal-title":"Med (Baltim)"},{"key":"3582_CR14","doi-asserted-by":"crossref","unstructured":"Shui M, Yang G, Jiang J, Wang S, Liao R. Mendelian randomization study of lipid metabolites reveals causal associations with age-related macular degeneration. Exp Gerontol 2025:112817.","DOI":"10.1016\/j.exger.2025.112817"},{"issue":"5","key":"3582_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/gepi.22385","volume":"45","author":"SM Lutz","year":"2021","unstructured":"Lutz SM, Wu AC, Hokanson JE, Vansteelandt S, Lange C. Caution against examining the role of reverse causality in Mendelian randomization. Genet Epidemiol. 2021;45(5):445\u201354.","journal-title":"Genet Epidemiol"},{"key":"3582_CR16","doi-asserted-by":"publisher","first-page":"104503","DOI":"10.1016\/j.ebiom.2023.104503","volume":"90","author":"ML Smith","year":"2023","unstructured":"Smith ML, Bull CJ, Holmes MV, Davey Smith G, Sanderson E, Anderson EL, Bell JA. Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study. EBioMedicine. 2023;90:104503.","journal-title":"EBioMedicine"},{"issue":"1","key":"3582_CR17","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1038\/s41598-024-58182-9","volume":"14","author":"H Zhou","year":"2024","unstructured":"Zhou H, Qi Y, Xu Y, Qi X, Qi H. Reverse causation between multiple sclerosis and psoriasis: a genetic correlation and Mendelian randomization study. Sci Rep. 2024;14(1):8845.","journal-title":"Sci Rep"},{"key":"3582_CR18","doi-asserted-by":"publisher","first-page":"107375","DOI":"10.1016\/j.phrs.2024.107375","volume":"208","author":"N Sharma","year":"2024","unstructured":"Sharma N, Singh L, Sharma A, Kumar A, Mahajan D. NAFLD-associated hepatocellular carcinoma (HCC) - A compelling case for repositioning of existing mTORc1 inhibitors. Pharmacol Res. 2024;208:107375.","journal-title":"Pharmacol Res"},{"issue":"8","key":"3582_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.gastha.2023.07.018","volume":"2","author":"H Toyoda","year":"2023","unstructured":"Toyoda H, Fujii H, Iwaki M, Hayashi H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, et al. Validation of noninvasive markers for HCC risk stratification in 1389 patients with Biopsy-proven NAFLD. Gastro Hep Adv. 2023;2(8):1093\u2013102.","journal-title":"Gastro Hep Adv"},{"key":"3582_CR20","doi-asserted-by":"publisher","first-page":"149781","DOI":"10.1016\/j.bbrc.2024.149781","volume":"707","author":"E Zheng","year":"2024","unstructured":"Zheng E, Chen Q, Xiao A, Luo X, Lu Q, Tian C, Liu H, Zhao J, Wei L, Yang P, et al. Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1\/2-ERK1\/2 signaling pathway. Biochem Biophys Res Commun. 2024;707:149781.","journal-title":"Biochem Biophys Res Commun"},{"key":"3582_CR21","doi-asserted-by":"crossref","unstructured":"Che L, Jiang R, Wang C, He J, Zhang Z, Qian B. Integrated network toxicology and population-based analysis uncovers organophosphate flame retardant exposure as a risk factor for hepatic steatosis and fibrosis: mechanistic and clinical insights. Int J Surg 2025.","DOI":"10.1097\/JS9.0000000000002680"},{"key":"3582_CR22","doi-asserted-by":"crossref","unstructured":"Claro M, Vinals C, Gimenez M, Perea V, Granados M, Seres-Noriega T, Blanco J, Vinagre I, Mesa A, Milad C et al. Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. Diabetes Res Clin Pract 2025:112334.","DOI":"10.1016\/j.diabres.2025.112334"},{"issue":"3","key":"3582_CR23","doi-asserted-by":"publisher","first-page":"e240402","DOI":"10.1148\/ryct.240402","volume":"7","author":"D Ueda","year":"2025","unstructured":"Ueda D, Uchida-Kobayashi S, Yamamoto A, Walston SL, Motoyama H, Fujii H, Watanabe T, Miki Y, Kawada N. Performance of a chest Radiograph-based deep learning model for detecting hepatic steatosis. Radiol Cardiothorac Imaging. 2025;7(3):e240402.","journal-title":"Radiol Cardiothorac Imaging"},{"key":"3582_CR24","first-page":"1209396","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Tao P, Fan P, Wang J, Rong T, Hou Y, Zhou Y, Lu W, Hong L, Ma L, Zhang Y, Tong H. Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma. Front Immunol. 2022;13:1209396.","journal-title":"Front Immunol"},{"issue":"17","key":"3582_CR25","first-page":"8802","volume":"15","author":"HY Pan","year":"2023","unstructured":"Pan HY, Wu QQ, Yin QQ, Dai YN, Huang YC, Zheng W, Hui TC, Chen MJ, Wang MS, Zhang JJ, Huang HJ, Tong YX. Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction. Aging. 2023;15(17):8802\u201320.","journal-title":"Aging"},{"issue":"11","key":"3582_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/cancers10110447","volume":"10","author":"H Nakagawa","year":"2018","unstructured":"Nakagawa H, Hayata Y, Kawamura S, Yamada T, Fujiwara N, Koike K. Lipid metabolic reprogramming in hepatocellular carcinoma. Cancers (Basel). 2018;10(11):447.","journal-title":"Cancers (Basel)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03582-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03582-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03582-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:51:52Z","timestamp":1759150312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03582-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3582"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03582-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not available.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1765"}}